Neochem Bio Solutions has successfully listed its Initial Public Offering on the NSE Emerge platform on 9th December, marking a key milestone in its growth journey within the specialty performance chemical industry. 

The company’s shares, issued at Rs. 98 per share, opened at Rs. 108 per share, registering a 10% premium on listing and demonstrating strong investor confidence. 

The positive listing reflects the market’s belief in Neochem Bio Solutions’ strategic roadmap, product innovation, and commitment to sustainable and value-driven chemical solutions. 

The IPO proceeds are expected to further accelerate the company’s expansion, strengthen operational capabilities, and enhance its ability to meet growing domestic and global market demand. 

Vivro Financial Services Private Limited is the book running lead manager to the issue, while MUFG Intime India Private Limited is registrar to the Issue. 

Neochem Bio Solutions was founded by Swapnil Rameshbhai Makati, and is a specialty performance chemical manufacturing company with a diverse portfolio across four primary product segments viz. polymers, surfactants, silicones and esters & biobased sustainable solutions. 

The company is catering to multiple industries including textile and garment washing, home & personal care (HPC), institutional & industrial cleaners, water treatment, paints & coatings, paper & pulp, construction, rubber and dyes & pigments. 

The company has an ISO certified manufacturing facility located in Ahmedabad with an installed production capacity of 22,000 MTPA, enabling efficient, high-quality, and scalable manufacturing operations. The company is accredited with GOTS 7.0 and ZDHC – Level 3.  

The company is backed by a strong distribution network of 50+ authorized distributors serving 225+ domestic customers, along with a growing customer presence across 12 countries. With 40 registered trademarks and a commitment to zero liquid discharge for sustainable operations, Neochem continues to strengthen its capabilities and expand its position in the specialty chemicals industry. 

During FY 25, the company achieved a revenue of Rs. 8,417.27 lakhs, EBITDA of Rs. 1,311.29 lakhs and PAT of Rs. 775.06 lakhs. For the six-month period ended September 2025, the company achieved a revenue of Rs. 4,583.16 lakhs, EBITDA of Rs. 859.22 lakhs and PAT of Rs. 548.38 lakhs.